ASTROCYTOMA, GRADE IV
Clinical trials for ASTROCYTOMA, GRADE IV explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA, GRADE IV trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, GRADE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for brain tumor patients: targeted drug shows promise in phase 3 trial
Disease control Recruiting nowThis study tests a drug called safusidenib in people with a type of brain tumor (glioma) that has a specific gene mutation (IDH1). The trial has three parts: one for recurrent tumors, one for high-risk tumors after standard treatment, and one for a specific tumor type after surge…
Matched conditions: ASTROCYTOMA, GRADE IV
Phase: PHASE3 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC
-
New hope for young brain cancer patients: targeted drug combo enters phase 2 trial
Disease control Recruiting nowThis study tests whether adding the drug olutasidenib to standard chemotherapy (temozolomide) can help children and young adults with a specific type of brain cancer (IDH1-mutant high-grade glioma) live longer. About 60 participants will receive the combination as maintenance the…
Matched conditions: ASTROCYTOMA, GRADE IV
Phase: PHASE2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Fat-Derived stem cells injected into brain during surgery to fight glioblastoma
Disease control Recruiting nowThis early-stage trial tests whether stem cells taken from fat tissue can be safely injected into the brain during surgery for recurrent glioblastoma. The stem cells are meant to attack remaining tumor cells and make them more sensitive to chemotherapy. About 20 adults whose brai…
Matched conditions: ASTROCYTOMA, GRADE IV
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New radiation technique aims to outsmart glioblastoma
Disease control Recruiting nowThis study tests a new way to deliver radiation therapy for glioblastoma, a fast-growing brain tumor. Instead of treating a large area, doctors use MRI-guided adaptive radiation to focus more precisely on the tumor with reduced margins. The goal is to see if this approach can bet…
Matched conditions: ASTROCYTOMA, GRADE IV
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC